Refractory myasthenia gravis exacerbation triggered By pembrolizumab.
Publication
, Journal Article
Earl, DE; Loochtan, AI; Bedlack, RS
Published in: Muscle Nerve
April 2018
Duke Scholars
Published In
Muscle Nerve
DOI
EISSN
1097-4598
Publication Date
April 2018
Volume
57
Issue
4
Start / End Page
E120 / E121
Location
United States
Related Subject Headings
- Skin Neoplasms
- Scalp
- Neurology & Neurosurgery
- Myasthenia Gravis
- Melanoma
- Male
- Lung Neoplasms
- Liver Neoplasms
- Humans
- Head and Neck Neoplasms
Citation
APA
Chicago
ICMJE
MLA
NLM
Earl, D. E., Loochtan, A. I., & Bedlack, R. S. (2018). Refractory myasthenia gravis exacerbation triggered By pembrolizumab. Muscle Nerve, 57(4), E120–E121. https://doi.org/10.1002/mus.26021
Earl, Damien E., Aaron I. Loochtan, and Richard S. Bedlack. “Refractory myasthenia gravis exacerbation triggered By pembrolizumab.” Muscle Nerve 57, no. 4 (April 2018): E120–21. https://doi.org/10.1002/mus.26021.
Earl DE, Loochtan AI, Bedlack RS. Refractory myasthenia gravis exacerbation triggered By pembrolizumab. Muscle Nerve. 2018 Apr;57(4):E120–1.
Earl, Damien E., et al. “Refractory myasthenia gravis exacerbation triggered By pembrolizumab.” Muscle Nerve, vol. 57, no. 4, Apr. 2018, pp. E120–21. Pubmed, doi:10.1002/mus.26021.
Earl DE, Loochtan AI, Bedlack RS. Refractory myasthenia gravis exacerbation triggered By pembrolizumab. Muscle Nerve. 2018 Apr;57(4):E120–E121.
Published In
Muscle Nerve
DOI
EISSN
1097-4598
Publication Date
April 2018
Volume
57
Issue
4
Start / End Page
E120 / E121
Location
United States
Related Subject Headings
- Skin Neoplasms
- Scalp
- Neurology & Neurosurgery
- Myasthenia Gravis
- Melanoma
- Male
- Lung Neoplasms
- Liver Neoplasms
- Humans
- Head and Neck Neoplasms